Home › Calculator › BGLC Dividend Calculator 2026
BGLC Dividend DRIP Calculator 2026
121.95% YieldIndustrialsBioNexus Gene Lab Corp. · NASDAQ
Price: $1.64 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BGLC pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BGLC snowball 📈
$10,000 in BGLC → $5299373494556.97M in 10 years · $441,261,104,261,101,250.00/month
About BioNexus Gene Lab Corp. (BGLC) — Dividend Analysis 2026
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Compare BGLC with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BGLC DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BGLC position with:
🌍 BGLC Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BGLC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 121.95% | 119.15% | $12,195 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 103.66% | 100.86% | $10,366 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 97.56% | 94.76% | $9,756 / yr |
| 🇬🇧 UK ISA | 0% | 121.95% | 119.15% | $12,195 / yr |
| 🇬🇧 UK Taxable | 8.75% | 111.28% | 108.48% | $11,128 / yr |
| 🇨🇦 TFSA | 0% | 121.95% | 119.15% | $12,195 / yr |
| 🇨🇦 CA Taxable | 25% | 91.46% | 88.66% | $9,146 / yr |
| 🇦🇺 Super (pension) | 15% | 103.66% | 100.86% | $10,366 / yr |
| 🇦🇺 AU Taxable | 30% | 85.36% | 82.56% | $8,536 / yr |
| 🇩🇪 DE Taxable | 26.375% | 89.79% | 86.99% | $8,979 / yr |
| 🇫🇷 FR Taxable | 30% | 85.36% | 82.56% | $8,536 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BGLC Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BGLC Dividend Payment Schedule
BGLC pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BGLC vs Industrials Benchmarks
How BGLC compares to typical Industrials averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BGLC sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BGLC Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-08-13 | 338,709 | $1.55 | $525.0K | ||
| A-Award | 2026-08-13 | 32,258 | $1.55 | $50.0K | ||
| A-Award | 2026-08-13 | 32,258 | $1.55 | $50.0K | ||
| A-Award | 2026-08-13 | 96,774 | $1.55 | $150.0K | ||
| A-Award | 2026-08-13 | 16,129 | $1.55 | $25.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where BGLC earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BGLC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
BioNexus Gene Lab Corp. (BGLC) is currently trading at $1.64, 99% below its 52-week high. The current dividend yield is 121.95% based on an annual payout of $2.00 per share.
BGLC (BioNexus Gene Lab Corp.) — 121.95% Dividend Yield Analysis
BioNexus Gene Lab Corp. (BGLC) is a industrials stock currently trading at $1.64 with a dividend yield of 121.95%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (121.95%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.